39 related articles for article (PubMed ID: 11368874)
1. Investigation of androgen receptor CAG repeats length in polycystic ovary syndrome diagnosed using the new international evidence-based guideline.
Yan X; Gao X; Shang Q; Yang Z; Wang Y; Liu L; Liu W; Liu D; Cheng F; Zhao S; Zhao H; Zhao J; Chen ZJ
J Ovarian Res; 2023 Nov; 16(1):211. PubMed ID: 37936145
[TBL] [Abstract][Full Text] [Related]
2. The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications.
Zhu H; Zhu X; Zheng L; Hu X; Sun L; Zhu X
Oncotarget; 2017 Apr; 8(17):29395-29405. PubMed ID: 27741511
[TBL] [Abstract][Full Text] [Related]
3. Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis.
Wang R; Goodarzi MO; Xiong T; Wang D; Azziz R; Zhang H
Mol Hum Reprod; 2012 Oct; 18(10):498-509. PubMed ID: 22695532
[TBL] [Abstract][Full Text] [Related]
4. Molecular Regulation of Androgen Receptors in Major Female Reproductive System Cancers.
Wu S; Yu K; Lian Z; Deng S
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886904
[TBL] [Abstract][Full Text] [Related]
5. The Role of Androgen Receptor Signaling in Ovarian Cancer.
Mizushima T; Miyamoto H
Cells; 2019 Feb; 8(2):. PubMed ID: 30791431
[TBL] [Abstract][Full Text] [Related]
6. The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer.
Meng X; Lu P; Chu Z; Fan Q
Oncotarget; 2016 Jan; 7(2):2105-12. PubMed ID: 26556855
[TBL] [Abstract][Full Text] [Related]
7. Hormone response in ovarian cancer: time to reconsider as a clinical target?
Modugno F; Laskey R; Smith AL; Andersen CL; Haluska P; Oesterreich S
Endocr Relat Cancer; 2012 Dec; 19(6):R255-79. PubMed ID: 23045324
[TBL] [Abstract][Full Text] [Related]
8. Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.
Zheng Y; Huo D; Zhang J; Yoshimatsu TF; Niu Q; Olopade OI
PLoS One; 2012; 7(7):e40494. PubMed ID: 22792352
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancer.
Ligr M; Patwa RR; Daniels G; Pan L; Wu X; Li Y; Tian L; Wang Z; Xu R; Wu J; Chen F; Liu J; Wei JJ; Lee P
PLoS One; 2011; 6(10):e26250. PubMed ID: 22022581
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women.
Chintamani ; Kulshreshtha P; Chakraborty A; Singh L; Mishra AK; Bhatnagar D; Saxena S
World J Surg Oncol; 2010 Aug; 8():64. PubMed ID: 20831839
[TBL] [Abstract][Full Text] [Related]
11. Combined profile of the tandem repeats CAG, TA and CA of the androgen and estrogen receptor genes in breast cancer.
Anghel A; Raica M; Marian C; Ursoniu S; Mitrasca O
J Cancer Res Clin Oncol; 2006 Nov; 132(11):727-33. PubMed ID: 16791593
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.
Terry KL; De Vivo I; Titus-Ernstoff L; Shih MC; Cramer DW
Cancer Res; 2005 Jul; 65(13):5974-81. PubMed ID: 15994977
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor trinucleotide polymorphism in leiomyoma.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Yeh LS; Peng CT
J Assist Reprod Genet; 2004 Dec; 21(12):453-7. PubMed ID: 15704521
[TBL] [Abstract][Full Text] [Related]
14. Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.
Menin C; Banna GL; De Salvo G; Lazzarotto V; De Nicolo A; Agata S; Montagna M; Sordi G; Nicoletto O; Chieco-Bianchi L; D'Andrea E
Cancer Lett; 2001 Jul; 168(1):31-6. PubMed ID: 11368874
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.
Dagan E; Friedman E; Paperna T; Carmi N; Gershoni-Baruch R
Eur J Hum Genet; 2002 Nov; 10(11):724-8. PubMed ID: 12404104
[TBL] [Abstract][Full Text] [Related]
16. CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.
Kim SC; Ju W; Mahavni V; Geisler JP; Buller RE
Int J Gynecol Cancer; 2006; 16 Suppl 1():190-4. PubMed ID: 16515589
[TBL] [Abstract][Full Text] [Related]
17. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
[TBL] [Abstract][Full Text] [Related]
18. The androgen receptor CAG repeat: a modifier of carcinogenesis?
Ferro P; Catalano MG; Dell'Eva R; Fortunati N; Pfeffer U
Mol Cell Endocrinol; 2002 Jul; 193(1-2):109-20. PubMed ID: 12161010
[TBL] [Abstract][Full Text] [Related]
19. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series.
Levine DA; Boyd J
Cancer Res; 2001 Feb; 61(3):908-11. PubMed ID: 11221880
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
